• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials

    • Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials
    • Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials
    • Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials storehouse
    • Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials quality testing
    • Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials quality testing
    • Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials certificate

    Product Overview:

    Moxifloxacin Hydrochloride is used for the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, and acute sinusitis caused by Staphylococcus aureus, H. influenzae, pneumococcus, Moraxella catarrhalis, and S. pneumoniae. Fluoroquinolone antimicrobials, Moxifloxacin Hydrochloride Powder is used for the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, Moxifloxacin Hydrochloride Raw Materials is used for the treatment of genitourinary infections, acute sinusitis. The efficacy is remarkable and the adverse effects are small.

    Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials Attributes

    Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials

    CAS: 186826-86-8

    MF: C21H25ClFN3O4

    Moxifloxacin hydrochloride

    MW: 437.8923032

    EINECS: 641-756-7

    Specification​: 99% min Moxifloxacin Hydrochloride

    Sample: Moxifloxacin Hydrochloride Powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Portal:https://henrikang.en.made-in-china.com/

    Moxifloxacin Hydrochloride Powder CAS 186826-86-8 Raw Materials Details

    Moxifloxacin Hydrochloride Powder Usage and Synthesis.

    Moxifloxacin Hydrochloride is used for the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, and acute sinusitis caused by Staphylococcus aureus, H. influenzae, pneumococcus, Moraxella catarrhalis, and other diseases. caused by Staphylococcus aureus, H. influenzae, pneumococcus, Moraxella catarrhalis, and S. pneumoniae.

    Fluoroquinolone antimicrobials, and other antimicrobials have been used in the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, and acute sinusitis.

     

    Moxifloxacin Hydrochloride Powder

    Moxifloxacin Hydrochloride Powder is used for the treatment of community-acquired pneumonia, acute exacerbation of chronic bronchitis, and for the prevention and treatment of chronic bronchitis.

    Moxifloxacin Hydrochloride Raw Materials is used for the treatment of genitourinary infections, acute sinusitis. The efficacy is remarkable and the adverse effects are small. The efficacy is remarkable and the adverse effects are small.

    The efficacy is remarkable and the adverse effects are small.

    Uses and functions of Moxifloxacin Hydrochloride Powder.

    Moxifloxacin Hydrochloride Powder is an antibiotic used to treat bacterial infections of the lungs, paranasal sinuses, skin, and abdominal cavity in adults.

    UsesFourth generation ultra-broad-spectrum quinolone antibiotic uses Fluoroquinolone antimicrobials,

    Moxifloxacin Hydrochloride Powder

    Moxifloxacin Hydrochloride is used for the treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, genitourinary infections, and acute sinusitis. It has significant therapeutic efficacy and low adverse effects.

    Moxifloxacin Hydrochloride Powder

    Pharmacological Effects of Moxifloxacin Hydrochloride Powder.

    The mechanism of action and in vitro antimicrobial spectrum of this product are similar to other fluoroquinolones, but the antimicrobial activity against gram-positive bacteria and anaerobes is similar to that of trovafloxacin (trovafloxacin) and superior to some older varieties.

    Few Gram-positive bacteria were resistant to moxifloxacin hydrochloride or resistance developed very slowly compared to other fluoroquinolones, and cross-resistant bacteria were found among Gram-negative bacteria and enterococci in comparison to other fluoroquinolones.

    Moxifloxacin Hydrochloride Powder

    However, it is effective against at least Staphylococcus aureus isolate beads grlA, grlB, gyrA or gyrB. 0.5-2mg/L of this product can inhibit ciprofloxacin-resistant S. aureus, which are ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin, and moxifloxacin, according to MICs in descending order.

    Production method of Moxifloxacin Hydrochloride Powder.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,